OMRELBA Trademark Information

Trademark by Atox Bio Inc.

Pharmaceutical preparation for the treatment of infection-related diseases and other conditions associated with a dysregulated immune system, namely, an immunomodulator for the treatment of suspected organ dysfunction or failure in patients with necrotizing soft tissue infections (NSTI) or NSTI with sepsis

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: OMRELBA
Status/Status Date:
PUBLICATION/ISSUE REVIEW COMPLETE
3/13/2021
Serial Number: 90341948
Filing Date: 11/25/2020
Foreign Filing Deadline: Tuesday, May 25, 2021
 
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparation for the treatment of infection-related diseases and other conditions associated with a dysregulated immune system, namely, an immunomodulator for the treatment of suspected organ dysfunction or failure in patients with necrotizing soft tissue infections (NSTI) or NSTI with sepsis
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 4/20/2021
Last Applicant/Owner:
Atox Bio Inc.
Durham, NC 27713
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
COVINGTON & BURLING LLP
ONE CITYCENTER, 850 TENTH STREET NW
WASHINGTON, DC 20001
Current Status:
PUBLICATION/ISSUE REVIEW COMPLETE
3/13/2021
Correspondent Search:
MARIE LAVALLEYE is a correspondent of OMRELBA trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on